Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a software update. The visible content and study information remain unchanged.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision was updated to v3.6.4, signaling an administrative update to the page version. This change does not modify any study details or content presented on the page.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study page version was updated from v3.6.2 to v3.6.3, signaling a minor revision to the record metadata.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision metadata has been updated from v3.6.0 to v3.6.2, indicating a newer version of the study details page.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now shows 'No longer looking for participants', signaling that recruitment has closed. It indicates the study is not accepting new participants.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's versioning rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.